机构:[1]Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China[2]Department of Oncology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, No. 354 Beima Road, Hongqiao District, Tianjin 300120, China[3]Department of Hepatobiliary Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China[4]Department of Radiotherapy, The Second Hospital of Tianjin Medical University, Tianjin 300211, China[5]Department of Gastric Cancer, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China[6]Department of Nursing, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Konggang Hospital, Tianjin 300300, China[7]Department of Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China[8]Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, No. 12 Health Road, Shijiazhuang 050000, Hebei, China临床科室肿瘤内科河北医科大学第四医院
This work was supported by the National Natural Science Foundation of China
(grant numbers 81702098) and Clinical Medical Research Project of Tianjin
Medical University (grant numbers 2017kylc004).
第一作者机构:[1]Department of Clinical Laboratory, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China
共同第一作者:
通讯作者:
通讯机构:[8]Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, No. 12 Health Road, Shijiazhuang 050000, Hebei, China
推荐引用方式(GB/T 7714):
Li Hongfeng,Wang Hailong,Cui Yunlong,et al.EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4[J].HEREDITAS.2023,160(1):doi:10.1186/s41065-023-00280-1.
APA:
Li Hongfeng,Wang Hailong,Cui Yunlong,Jiang Wenhua,Zhan Hongjie...&Liu Pengfei.(2023).EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.HEREDITAS,160,(1)
MLA:
Li Hongfeng,et al."EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4".HEREDITAS 160..1(2023)